| Primary |
| Hypertension |
35.3% |
| Coronary Artery Bypass |
11.8% |
| Drug Use For Unknown Indication |
11.8% |
| Rheumatoid Arthritis |
11.8% |
| Cerebrovascular Accident |
5.9% |
| Chronic Obstructive Pulmonary Disease |
5.9% |
| Diabetes Mellitus |
5.9% |
| Myocardial Infarction |
5.9% |
| Toxicity To Various Agents |
5.9% |
|
| Renal Failure Chronic |
14.3% |
| Completed Suicide |
7.1% |
| Death |
7.1% |
| Lower Respiratory Tract Infection |
7.1% |
| Myocardial Infarction |
7.1% |
| Overdose |
7.1% |
| Swollen Tongue |
7.1% |
| Throat Tightness |
7.1% |
| Thrombocytopenia |
7.1% |
| Thrombosis |
7.1% |
| Tremor |
7.1% |
| Viral Infection |
7.1% |
| Walking Disability |
7.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.3% |
| Hypertension |
18.3% |
| Product Used For Unknown Indication |
12.0% |
| Depression |
5.6% |
| Diabetes Mellitus |
4.2% |
| Antiphospholipid Syndrome |
2.8% |
| Crohn's Disease |
2.8% |
| Embolism Arterial |
2.8% |
| Renal Failure |
2.8% |
| Cerebrovascular Accident |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Essential Hypertension |
2.1% |
| Ill-defined Disorder |
2.1% |
| Cardiac Failure Congestive |
1.4% |
| Cardiovascular Disorder |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Major Depression |
1.4% |
| Prophylaxis |
1.4% |
| Renal Failure Chronic |
1.4% |
| Schizophrenia |
1.4% |
|
| Myocardial Infarction |
10.3% |
| Drug Interaction |
7.7% |
| Renal Failure |
7.7% |
| Ventricular Extrasystoles |
7.7% |
| Walking Disability |
7.7% |
| White Blood Cell Count Increased |
7.7% |
| Glomerular Filtration Rate Decreased |
5.1% |
| Glomerulonephritis |
5.1% |
| Haematuria |
5.1% |
| Renal Failure Acute |
5.1% |
| Renal Impairment |
5.1% |
| Therapeutic Response Decreased |
5.1% |
| Blood Triglycerides Increased |
2.6% |
| Bradycardia |
2.6% |
| General Physical Health Deterioration |
2.6% |
| Henoch-schonlein Purpura |
2.6% |
| Hyperkalaemia |
2.6% |
| Hypersensitivity |
2.6% |
| Hypertension |
2.6% |
| Hyponatraemia |
2.6% |
|
| Concomitant |
| Hypertension |
22.0% |
| Drug Use For Unknown Indication |
19.1% |
| Product Used For Unknown Indication |
12.9% |
| Diabetes Mellitus |
7.6% |
| Type 2 Diabetes Mellitus |
4.3% |
| Prophylaxis |
4.2% |
| Atrial Fibrillation |
3.7% |
| Myocardial Ischaemia |
3.3% |
| Acute Myocardial Infarction |
2.8% |
| Acute Coronary Syndrome |
2.7% |
| Hypercholesterolaemia |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Multiple Myeloma |
2.2% |
| Coronary Artery Disease |
1.9% |
| Hyperlipidaemia |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Dyslipidaemia |
1.4% |
| Osteoporosis |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Hypothyroidism |
1.2% |
|
| Vomiting |
10.3% |
| Myocardial Infarction |
8.2% |
| Renal Failure |
7.6% |
| Renal Failure Acute |
7.6% |
| Cerebrovascular Accident |
6.0% |
| Urticaria |
5.4% |
| Weight Decreased |
5.4% |
| Renal Impairment |
4.9% |
| Death |
4.3% |
| Pancreatitis Acute |
4.3% |
| Sepsis |
4.3% |
| Left Ventricular Dysfunction |
3.8% |
| Pulmonary Embolism |
3.8% |
| Pulmonary Oedema |
3.8% |
| Thrombocytopenia |
3.8% |
| Cardiac Failure Congestive |
3.3% |
| Hypertension |
3.3% |
| Hyponatraemia |
3.3% |
| Myocardial Ischaemia |
3.3% |
| Urinary Tract Infection |
3.3% |
|
| Interacting |
| Hypertension |
44.4% |
| Diabetes Mellitus |
22.2% |
| Product Used For Unknown Indication |
16.7% |
| Epilepsy |
11.1% |
| Gastrooesophageal Reflux Disease |
5.6% |
|
| Drug Interaction |
75.0% |
| Palpitations |
25.0% |
|
